Compound Detail
CHEMBL300138
ENZASTAURIN 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21
Basic Information
| ChEMBL ID | CHEMBL300138 |
| Name | ENZASTAURIN |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | AXRCEOKUDYDWLF-UHFFFAOYSA-N |
83
Targets
118
Activities
2
Assay Types
1
PK Parameters
20
Publications
8
Known Names
20
Indications
1
Mechanisms
Molecular Properties
515.6
MW (Da)
4.93
ALogP
6
HBA
1
HBD
72.2
PSA (Ų)
0.34
QED
1
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Protein kinase C beta inhibitor | INHIBITOR | Protein kinase C beta type | ✓ | ✓ |
Indications
Ehlers-Danlos Syndrome Glioblastoma Lymphoma, Non-Hodgkin Breast Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma, Renal Cell Colorectal Neoplasms Colorectal Neoplasms Fallopian Tube Neoplasms Glioma Lung Neoplasms Lymphoma Lymphoma, Follicular Lymphoma, Follicular Lymphoma, Large B-Cell, Diffuse Lymphoma, Mantle-Cell Lymphoma, T-Cell, Cutaneous Multiple Myeloma Neoplasms Neoplasms
Activity Summary
Kd 96 meas. best 8.08
IC50 22 meas. best 8.22
Target Activity Profile
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 6.0 | uL.min-1.(10^6cells)-1 | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL4689842 | U2OS | 262 |
| - | 10.6019/CHEMBL4689842 | Fibroblast | 260 |
| - | 10.6019/CHEMBL4689842 | HEK-293T | 260 |
| 22037378 | 10.1038/nbt.1990 | Tyrosine-protein kinase ABL1 | 15 |
| 22037378 | 10.1038/nbt.1990 | Epidermal growth factor receptor | 12 |
| - | 10.6019/CHEMBL5674860 | Colon cancer organoid | 12 |
| - | 10.6019/CHEMBL5724558 | Colon cancer organoid | 12 |
| 22037378 | 10.1038/nbt.1990 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 10 |
| - | 10.6019/CHEMBL5724696 | U2OS | 8 |
| 22037378 | 10.1038/nbt.1990 | Mast/stem cell growth factor receptor Kit | 8 |
| 22037378 | 10.1038/nbt.1990 | Receptor-type tyrosine-protein kinase FLT3 | 7 |
| - | 10.6019/CHEMBL5608141 | Colon cancer organoid | 6 |
| 29191878 | 10.1126/science.aan4368 | Unchecked | 5 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 22037378 | 10.1038/nbt.1990 | Proto-oncogene tyrosine-protein kinase receptor Ret | 4 |
| 22037378 | 10.1038/nbt.1990 | Hepatocyte growth factor receptor | 3 |
| - | 10.6019/CHEMBL5212743 | Receptor-type tyrosine-protein kinase FLT3 | 3 |
| 22037378 | 10.1038/nbt.1990 | Ribosomal protein S6 kinase alpha-5 | 2 |
| 22037378 | 10.1038/nbt.1990 | Ribosomal protein S6 kinase alpha-6 | 2 |
| 22037378 | 10.1038/nbt.1990 | Non-receptor tyrosine-protein kinase TYK2 | 2 |
Data from ChEMBL 36 via Core Engine